Physician profile
Rita Seddeik
NPI 1891304648
$1,293.45
in general payments reported to CMS, 2019-2025
7 companies · $87.89 in 2025
The $87.89 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.02 · 2022: $310 · 2023: $746 · 2024: $82.79 · 2025: $87.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $648.17 | 2023 | Nobelactive |
| Align Technology, INC. | $236.02 | 2022-2025 | Invisalign, Invisalign Go, Itero Element 2 Plus |
| Kerr Corporation | $171.67 | 2021-2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $168.47 | 2022-2025 | Arestin |
| Gc America INC. | $46.77 | 2025 | Cytrans Granules |
| Colgate Oral Pharmaceuticals, INC. | $13.77 | 2023 | |
| Ultradent Products INC | $8.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Seddeik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.